4//SEC Filing
Kemble George 4
Accession 0001104659-25-115071
CIK 0001400118other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:13 PM ET
Size
5.4 KB
Accession
0001104659-25-115071
Insider Transaction Report
Form 4
Kemble George
DirectorExecutive Chairman
Transactions
- Sale
Series A Common Stock
2025-11-20$7.69/sh−37,688$289,979→ 81,005 total
Footnotes (2)
- [F1]These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.27 to $8.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001858176
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:13 PM ET
- Size
- 5.4 KB